Allianz Asset Management »

Crispr Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $960k 15k 62.60
2023-09-30 $637k 14k 45.39
2023-06-30 $3.1M 56k 56.14
2023-03-31 $2.4M 54k 45.23
2022-12-31 $2.1M 51k 40.65
2022-09-30 $3.7M 50k 72.73
2022-06-30 $1.6M 27k 60.00
2022-03-31 $1.7M 27k 62.76
2021-12-31 $3.3M 43k 75.78
2021-09-30 $4.7M 42k 111.91
2021-06-30 $11M 66k 161.88
2021-03-31 $3.1M 26k 121.84
2020-12-31 $3.4M 22k 153.11
2020-03-31 $3.5M 82k 42.41
2019-12-31 $2.1M 34k 60.92
2019-09-30 $1.6M 40k 40.98
2019-06-30 $2.8M 60k 47.09
2019-03-31 $2.8M 80k 35.72
2018-12-31 $1.8M 62k 28.56
2018-09-30 $2.7M 60k 44.35
2018-06-30 $7.4M 126k 58.76
2018-03-31 $11M 233k 45.71
2017-12-31 $5.4M 232k 23.48
2017-09-30 $2.4M 133k 17.87